AT290032B - Verfahren zur Herstellung von neuem N<α><(A1)>,Nγ<(B29)>-Di-tert.Butyloxycarbonyl-insulin - Google Patents

Verfahren zur Herstellung von neuem N<α><(A1)>,Nγ<(B29)>-Di-tert.Butyloxycarbonyl-insulin

Info

Publication number
AT290032B
AT290032B AT913469A AT913469A AT290032B AT 290032 B AT290032 B AT 290032B AT 913469 A AT913469 A AT 913469A AT 913469 A AT913469 A AT 913469A AT 290032 B AT290032 B AT 290032B
Authority
AT
Austria
Prior art keywords
butyloxycarbonyl
insulin
tert
new
production
Prior art date
Application number
AT913469A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AT290032B publication Critical patent/AT290032B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT913469A 1968-09-28 1969-09-26 Verfahren zur Herstellung von neuem N<α><(A1)>,Nγ<(B29)>-Di-tert.Butyloxycarbonyl-insulin AT290032B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1793517A DE1793517C3 (de) 1968-09-28 1968-09-28 N(Al),N(B29>Bis-(tert.-butyloxycarbonyl)-insulin und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
AT290032B true AT290032B (de) 1971-05-10

Family

ID=5707736

Family Applications (1)

Application Number Title Priority Date Filing Date
AT913469A AT290032B (de) 1968-09-28 1969-09-26 Verfahren zur Herstellung von neuem N<α><(A1)>,Nγ<(B29)>-Di-tert.Butyloxycarbonyl-insulin

Country Status (10)

Country Link
US (1) US3684791A (de)
AT (1) AT290032B (de)
BE (1) BE739511A (de)
CH (1) CH530207A (de)
DE (1) DE1793517C3 (de)
DK (1) DK123094B (de)
FR (1) FR2019135A1 (de)
GB (1) GB1223350A (de)
NL (1) NL159089B (de)
SE (1) SE362872B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934008A (en) * 1968-08-23 1976-01-20 Ciba-Geigy Corporation N-acyl and desamino human calcitonin and analogs thereof
GB1381274A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
GB1381273A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
US3864325A (en) * 1971-11-18 1975-02-04 Nat Res Dev (N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives
KR20010024556A (ko) 1997-10-24 2001-03-26 피터 지. 스트링거 불용성 인슐린 조성물
US6531448B1 (en) * 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
US7040519B2 (en) * 2003-06-12 2006-05-09 Jere F. Irwin Thermoformable web support apparatus and support device for a heated plastic sheet
EP2391218B1 (de) 2009-01-28 2020-03-18 Smartcells, Inc. Konjugatbasierte systeme für kontrollierte wirkstofffreisetzung
JP2012516340A (ja) 2009-01-28 2012-07-19 スマートセルズ・インコーポレイテツド 合成コンジュゲートおよびその使用
WO2010088268A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
CN102341409A (zh) 2009-01-28 2012-02-01 斯马特塞尔斯公司 结晶胰岛素-缀合物
EP2408470A4 (de) 2009-03-20 2012-08-29 Smartcells Inc Lösliche nichtdepot-insulinkonjugate und ihre verwendung
EP2408808A4 (de) 2009-03-20 2015-05-06 Smartcells Inc Terminal-funktionalisierte konjugate und ihre verwendung
US9068013B2 (en) 2010-07-28 2015-06-30 Smart Cells, Inc. Recombinant lectins, binding-site modified lectins and uses thereof
US9074015B2 (en) 2010-07-28 2015-07-07 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
CA2805739A1 (en) 2010-07-28 2012-02-02 Smartcells, Inc. Drug-ligand conjugates, synthesis thereof, and intermediates thereto
BR112016007176A2 (pt) 2013-10-04 2018-01-23 Merck Sharp & Dohme conjugado, composição, usos de um conjugado e de uma composição, e, método para tratar um indivíduo que tem diabete
FR3120445B1 (fr) 2021-03-08 2023-02-10 Aryballe Procédé de caractérisation d’un analyte présent dans un échantillon gazeux contenant au moins une espèce chimique parasite

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3528960A (en) * 1968-10-07 1970-09-15 Lilly Co Eli N-carboxyaroyl insulins

Also Published As

Publication number Publication date
NL6914400A (de) 1970-04-01
DE1793517C3 (de) 1974-12-05
FR2019135A1 (de) 1970-06-26
SE362872B (de) 1973-12-27
CH530207A (de) 1972-11-15
BE739511A (de) 1970-03-31
US3684791A (en) 1972-08-15
DE1793517A1 (de) 1972-03-02
DE1793517B2 (de) 1974-05-09
NL159089B (nl) 1979-01-15
DK123094B (da) 1972-05-15
GB1223350A (en) 1971-02-24

Similar Documents

Publication Publication Date Title
AT290032B (de) Verfahren zur Herstellung von neuem N&lt;α&gt;&lt;(A1)&gt;,Nγ&lt;(B29)&gt;-Di-tert.Butyloxycarbonyl-insulin
CH546241A (de) Verfahren zur herstellung von 6,7-benzomorphanen.
CH580082A5 (de) Verfahren zur herstellung von 2,4-diamino-5-benzylpyrimidinen.
CH546805A (de) Verfahren zur herstellung von polyphenylenoxyden.
CH557410A (de) Verfahren zur herstellung von neuen reaktivfarbstoffen.
AT298451B (de) Verfahren zur Herstellung von neuen, basisch substituierten Phenolen
CH547290A (de) Verfahren zur herstellung von nitro-imidazolderivaten.
CH495529A (de) Verfahren zur Herstellung rohrförmiger, radioaktiver Lichtquellen
DE2021297B2 (de) Verfahren zur herstellung von 4,4&#39;thio-bis-(2,6-di-tert.butylphenol)
CH535249A (de) Verfahren zur Herstellung von 2-Amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin
CH549010A (de) Verfahren zur herstellung von novenamin.
CH549046A (de) Verfahren zur herstellung von 8-substituierten 10-piperazino-10, 11-dihydrodibenzo-(b,f)-thiepinen.
CH557861A (de) Verfahren zur herstellung von perinonfarbstoffen.
CH554858A (de) Verfahren zur herstellung von methyl-n-acetal-6,7-aziridino-6-desamino-7-desoxy-(alpha)-thiolincosamidinen.
CH546720A (de) Verfahren zur herstellung von citronellal.
CH492680A (de) Verfahren zur Herstellung von (4-Phenoxy-3,5-dihalogenphenyl)-carbonsäure- bzw. alkancarbonsäureamiden
CH548979A (de) Verfahren zur herstellung von chalconderivaten.
CH552033A (de) Verfahren zur herstellung von monoazofarbstoffen.
CH546270A (de) Verfahren zur herstellung wasserloeslicher, faseraffiner schwefelfarbstoffe.
CH555702A (de) Verfahren zur herstellung von feingeteiltem feststoff.
CH546211A (de) Verfahren zur herstellung von fluorjodalkanen.
CH555850A (de) Verfahren zur herstellung von 3-aryl-benzazinen.
CH547258A (de) Verfahren zur herstellung von (epsilon)-aminocapronsaeure.
CH491936A (de) Verfahren zur Herstellung von Chinoxalin-1,4-dioxyden
CH550781A (de) Verfahren zur herstellung von cholesta-5,7-dien-3(beta),25diol.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee